8113:TSEUnicharm Corporation Analysis
Data as of 2026-03-11 - not real-time
HK$0.40
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Technical outlook: The stock is trading at HKD 0.40, exactly at the computed support level, while the 20‑day SMA sits at 0.429 and the 50‑day SMA at 0.392, indicating a narrow upward bias but limited upside. RSI is at 37.6, edging toward oversold, yet the MACD histogram is negative and the signal line is bearish, and volume has been decreasing, all pointing to short‑term pressure.
Fundamental health: Earnings are negative (trailing EPS ‑0.03) with a profit margin of ‑0.3 % and operating cash flow of ‑31.8 million HKD, while debt‑to‑equity is an elevated 117 %, suggesting a strained balance sheet. The price‑to‑book of 0.64 and price‑to‑sales of 0.065 make the stock appear cheap on a valuation basis, but the lack of dividend and negative cash generation undermine that appeal.
Risk & valuation perspective: The stock exhibits high 30‑day volatility (≈40 %) but a low beta (≈0.47), indicating market‑wide moves have limited impact while the stock itself swings sharply. Geographic concentration in China, sector cyclicality, and a historic max drawdown of ‑50 % add to the risk profile, leading to an overall risk score of 8/10. The company is therefore undervalued from a book‑value standpoint yet fundamentally weak, warranting caution.
Fundamental health: Earnings are negative (trailing EPS ‑0.03) with a profit margin of ‑0.3 % and operating cash flow of ‑31.8 million HKD, while debt‑to‑equity is an elevated 117 %, suggesting a strained balance sheet. The price‑to‑book of 0.64 and price‑to‑sales of 0.065 make the stock appear cheap on a valuation basis, but the lack of dividend and negative cash generation undermine that appeal.
Risk & valuation perspective: The stock exhibits high 30‑day volatility (≈40 %) but a low beta (≈0.47), indicating market‑wide moves have limited impact while the stock itself swings sharply. Geographic concentration in China, sector cyclicality, and a historic max drawdown of ‑50 % add to the risk profile, leading to an overall risk score of 8/10. The company is therefore undervalued from a book‑value standpoint yet fundamentally weak, warranting caution.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- price testing support at HKD 0.40
- bearish MACD histogram and signal line
- declining volume coupled with high 30‑day volatility
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- price‑to‑book of 0.64 suggests relative cheapness
- potential recovery in Chinese consumer‑electronics demand
- high debt‑to‑equity and negative cash flow remain concerns
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- lack of dividend and ongoing earnings losses
- exposure to cyclical electronic components sector
- opportunity if the company successfully pivots to higher‑margin design services
Key Metrics & Analysis
Financial Health
Revenue Growth-13.40%
Profit Margin-0.32%
ROE-3.56%
ROA0.95%
Debt/Equity116.86
P/B Ratio0.6
Op. Cash FlowHK$-31775000
Free Cash FlowHK$-15314000
Industry P/E36.8
Technical Analysis
TrendNeutral
RSI37.6
SupportHK$0.40
ResistanceHK$0.44
MA 20HK$0.43
MA 50HK$0.39
MA 200HK$0.40
MACDBearish
VolumeDecreasing
Fear & Greed Index76.91
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta0.47
Volatility40.16%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.